Repatha (evolocumab)

pCPA File Number: 22741
Negotiation Status:
Active Negotiation
Indication(s):
Atherosclerotic cardiovascular disease
Sponsor/Manufacturer:
Amgen Canada Inc.
CDA-AMC Project Number:
SR0821-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable